Trial Profile

A Phase 1 First-in-human clinical trial of GB7208 in healthy volunteers.

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 17 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs GB 7208 (Primary)
Indications Multiple sclerosis
Focus Adverse reactions; First in man

Most Recent Events

10 May 2022 According to Gossamer Bio media release, the company expects to initiate this study in the first half of 2023.
15 Oct 2021 New trial record
11 Oct 2021 According to Gossamer Bio media release, First-in-human Phase 1 clinical trial expected to initiate in the second half of 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com